Tag Archives: Sarepta

Sarepta Stock Soars. Why Layoffs and a ‘Black-Box’ Warning Are Good News.  Barron’s Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting  The Boston Globe Sarepta Soars as Gene Therapy Stays on Market With Warning  Bloomberg Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks  BioPharma Dive Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box …

TSMC, United, Sarepta, PepsiCo, GE Aerospace, MP Materials, Archer Daniels, and More Movers  Barron’s Stocks making the biggest premarket moves: PepsiCo, Starbucks, General Electric, Cars.com and more  CNBC Stocks to Watch Thursday: TSMC, United Airlines, GE Aerospace  The Wall Street Journal Stock Movers: Lucid, United, GE  Bloomberg Netflix, PepsiCo and GE Aerospace rise premarket; United Airlines falls  Investing.com Source link

Sarepta Therapeutics to Restructure, Lay Off 500 Workers  The Wall Street Journal Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta Therapeutics Sarepta Stock Soars 30%. Why Layoffs and a ‘Black-Box’ Warning Are Good News.  Barron’s Sarepta Soars as Gene Therapy Stays on Market With Warning  Bloomberg Sarepta Tags DMD Gene Therapy …

Sarepta to cut 500 jobs, add black-box warning on gene therapy  Reuters Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta Therapeutics Sarepta Soars as Gene Therapy Stays on Market With Warning  Bloomberg Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning  Fierce Biotech Sarepta Therapeutics Halts …

Sarepta Soars as Gene Therapy Stays on Market With Warning  Bloomberg Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta Therapeutics Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning  Fierce Biotech Sarepta Therapeutics Halts ELEVIDYS Shipments for Non-Ambulatory DMD Patients  Yahoo Finance Sarepta Therapeutics lays off …

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. Sarepta Therapeutics laid off more than one-third of its workforce, …

Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta TherapeuticsView Full Coverage on Google News Source link